Podda A - Search Results

1

Towards third-generation whooping cough vaccines.

Rappuoli R, Pizza M, Podda A, De Magistris MT, Nencioni L. Rappuoli R, et al. Among authors: podda a. Trends Biotechnol. 1991 Jul;9(7):232-8. doi: 10.1016/0167-7799(91)90076-t. Trends Biotechnol. 1991. PMID: 1370047 Review.

2

Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.

Rappuoli R, Pizza M, Covacci A, Bartoloni A, Nencioni L, Podda A, De Magistris MT. Rappuoli R, et al. Among authors: podda a. FEMS Microbiol Immunol. 1992 Oct;5(4):161-70. doi: 10.1111/j.1574-6968.1992.tb05898.x. FEMS Microbiol Immunol. 1992. PMID: 1384602

3

Progress towards the development of new vaccines against whooping cough.

Rappuoli R, Podda A, Pizza M, Covacci A, Bartoloni A, de Magistris MT, Nencioni L. Rappuoli R, et al. Among authors: podda a. Vaccine. 1992;10(14):1027-32. doi: 10.1016/0264-410x(92)90112-w. Vaccine. 1992. PMID: 1471424 Review.

4

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C.

Costantino P, Viti S, Podda A, Velmonte MA, Nencioni L, Rappuoli R. Costantino P, et al. Among authors: podda a. Vaccine. 1992;10(10):691-8. doi: 10.1016/0264-410x(92)90091-w. Vaccine. 1992. PMID: 1523880 Clinical Trial.

5

Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children.

Podda A, De Luca EC, Titone L, Casadei AM, Cascio A, Peppoloni S, Volpini G, Marsili I, Nencioni L, Rappuoli R. Podda A, et al. J Pediatr. 1992 May;120(5):680-5. doi: 10.1016/s0022-3476(05)80227-6. J Pediatr. 1992. PMID: 1578301

6

Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin.

Rappuoli R, Pizza M, De Magistris MT, Podda A, Bugnoli M, Manetti R, Nencioni L. Rappuoli R, et al. Among authors: podda a. Immunobiology. 1992 Feb;184(2-3):230-9. doi: 10.1016/S0171-2985(11)80477-8. Immunobiology. 1992. PMID: 1587545 Review.

7

[A phase-I clinical trial of a new antitetanus/antidiphtheria vaccine for adults].

Podda A, Vescia N, Donati D, Marsili I, Volpini G, Nencioni L, Mastroeni I, Rappuoli R, Fara GM. Podda A, et al. Ann Ig. 1991 Mar-Apr;3(2):79-84. Ann Ig. 1991. PMID: 1725595 Clinical Trial. Italian. No abstract available.

8

Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.

Podda A, Nencioni L, Marsili I, Peppoloni S, Volpini G, Donati D, Di Tommaso A, De Magistris MT, Rappuoli R. Podda A, et al. Vaccine. 1991 Oct;9(10):741-5. doi: 10.1016/0264-410x(91)90290-m. Vaccine. 1991. PMID: 1759492 Clinical Trial.

9

Genetic approaches to a vaccine for pertussis.

Nencioni L, Pizza M, Volpini G, Podda A, Rappuoli R. Nencioni L, et al. Among authors: podda a. Adv Exp Med Biol. 1991;303:119-27. doi: 10.1007/978-1-4684-6000-1_14. Adv Exp Med Biol. 1991. PMID: 1805560 Clinical Trial. No abstract available.

10

Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

Podda A, Nencioni L, De Magistris MT, Di Tommaso A, Bossù P, Nuti S, Pileri P, Peppoloni S, Bugnoli M, Ruggiero P, et al. Podda A, et al. J Exp Med. 1990 Sep 1;172(3):861-8. doi: 10.1084/jem.172.3.861. J Exp Med. 1990. PMID: 2201750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters